ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Wittes To Return To NCI As Chief Of Medicine Branch; Owens Heads Cancer Research Coalition

June 8, 1990

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

NCI To Stop All Support For WHT After March 31

February 5, 1988

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984